StreptomeDB: A resource for natural compounds isolated from Streptomyces species

Nucleic Acids Research

Volumn 41, Issue D1, 2013, Pages

  Lucas, Xavier ^a   Senger, Christian ^a   Erxleben, Anika ^a   Grüning, Björn A ^a   Döring, Kersten ^a   Mosch, Johannes ^a   Flemming, Stephan ^a   Günther, Stefan ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

NATURAL PRODUCT;

ARTICLE; BACTERIAL STRAIN; BIOINFORMATICS; BIOSYNTHESIS; CHEMICAL STRUCTURE; DATA EXTRACTION; DATA MINING; DRUG DATABASE; INFORMATION RETRIEVAL; PRIORITY JOURNAL; STREPTOMEDB; STREPTOMYCES; VIRTUAL REALITY;

DATABASES, CHEMICAL; DRUG DISCOVERY; DRUG RESISTANCE, BACTERIAL; INTERNET; STREPTOMYCES;

STREPTOMYCES;

EID: 84876543738     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gks1253     Document Type: Article

References (40)

1. Hopwood, D.A. (2007) Streptomyces in Nature and Medicine: The Antibiotic Markers. Oxford University Press, NY, USA.
2. Mitchell, W. (2011) Natural products from synthetic biology. Curr. Opin. Chem. Biol., 15, 505-515.
3. Labeda, D.P., Goodfellow, M., Brown, R., Ward, A.C., Lanoot, B., Vanncanneyt, M., Swings, J., Kim, S.B., Liu, Z., Chun, J. et al. (2012) Phylogenetic study of the species within the family Streptomycetaceae. Antonie Van Leeuwenhoek, 101, 73-104.
4. Berdy, J. (2005) Bioactive microbial metabolites. J. Antibiot., 58, 1-26.
5. Papagianni, M. (2012) Recent advances in engineering the central carbon metabolism of industrially important bacteria. Microb. Cell Fact., 11, 50.
6. Goff, G.L., Martin, M.T., Servy, C., Cortial, S., Lopes, P., Bialecki, A., Smadja, J. and Ouazzani, J. (2012) Isolation and characterization of α, β-unsaturated γ-lactono-hydrazides from Streptomyces sp. J. Nat. Prod., 75, 915-919.
7. Wenzel, S.C., Bode, H.B., Kochems, I. and Müller, R. (2008) A type I/type III polyketide synthase hybrid biosynthetic pathway for the structurally unique ansa compound kendomycin. Chembiochem, 9, 2711-2721.
8. Kamal, A., Rao, M.V., Laxman, N., Ramesh, G. and Reddy, G.S. (2002) Recent developments in the design, synthesis and structure-activity relationship studies of pyrrolo[2, 1-c][1, 4] benzodiazepines as DNA-interactive antitumour antibiotics. Curr. Med. Chem. Anticancer Agents, 2, 215-254.
9. Chen, Y., Luo, Y., Ju, J., Wendt-Pienkowski, E., Rajski, S.R. and Shen, B. (2008) Identification of fredericamycin E from Streptomyces griseus: insights into fredericamycin A biosynthesis highlighting carbaspirocycle formation. J. Nat. Prod., 71, 431-437.
10. Ghatge, M., Palaniappan, N., Choudhuri, S.D. and Reynolds, K. (2006) Genetic manipulation of the biosynthetic process leading to phoslactomycins, potent protein phosphatase 2A inhibitors. J. Ind. Microbiol. Biotechnol., 33, 589-599.
11. Zhang, W., Ames, B.D., Tsai, S.C. and Tang, Y. (2006) Engineered biosynthesis of a novel amidated polyketide, using the malonamyl-specific initiation module from the oxytetracycline polyketide synthase. Appl. Environ. Microbiol., 72, 2573-2580.
12. Moore, B.S., Kalaitzis, J.A. and Xiang, L. (2005) Exploiting marine actinomycete biosynthetic pathways for drug discovery. Antonie Van Leeuwenhoek, 87, 49-57.
13. McDaniel, R., Thamchaipenet, A., Gustafsson, C., Fu, H., Betlach, M. and Ashley, G. (1999) Multiple genetic modifications of the erythromycin polyketide synthase to produce a library of novel "unnatural" natural products. Proc. Natl Acad. Sci. USA, 96, 1846-1851.
14. Genilloud, O., González, I., Salazar, O., Martín, J., Tormo, J.R. and Vicente, F. (2011) Current approaches to exploit actinomycetes as a source of novel natural products. J. Ind. Microbiol. Biotechnol., 38, 375-389.
15. Grüning, B.A., Senger, C., Erxleben, A., Flemming, S. and Günther, S. (2011) Compounds In Literature (CIL): screening for compounds and relatives in PubMed. Bioinformatics, 27, 1341-1342.
16. Afendi, F.M., Okada, T., Yamazaki, M., Hirai-Morita, A., Nakamura, Y., Nakamura, K., Ikeda, S., Takahashi, H., Ul-Amin, M.A., Darusman, L.K. et al. (2012) KNApSAcK family databases: integrated metabolite-plant species databases for multifaceted plant research. Plant Cell Physiol., 53, e1.
17. Lewell, X.Q., Judd, D.B., Watson, S.P. and Hann, M.M. (1998) RECAP - retrosynthetic combinatorial analysis procedure: a powerful new technique for identifying privileged molecular fragments with useful applications in combinatorial chemistry. J. Chem. Inf. Comput. Sci., 38, 511-522.
18. O'Boyle, N.M., Banck, M., James, C.A., Morley, C., Vandermeersch, T. and Hutchison, G.R. (2011) Open Babel: an open chemical toolbox. J. Cheminform., 3, 33.
19. Khanna, V. and Ranganathan, S. (2011) Structural diversity of biologically interesting datasets: a scaffold analysis approach. J. Cheminform., 3, 30.
20. Sessa, C., Valota, O. and Geroni, C. (2007) Ongoing phase I and II studies of novel anthracyclines. Cardiovasc. Toxicol., 7, 75-79.
21. Hur, G.H., Vickery, C.R. and Burkart, M.D. (2012) Explorations of catalytic domains in non-ribosomal peptide synthetase enzymology. Nat. Prod. Rep., 29, 1074-1098.
22. Caboche, S., Pupin, M., Leclere, V., Fontaine, A., Jacques, P. and Kucherov, G. (2008) NORINE: a database of nonribosomal peptides. Nucleic Acids Res., 36, D326-D331.
23. Koehn, F.E. and Carter, G.T. (2005) The evolving role of natural products in drug discovery. Nat. Rev. Drug Discov., 4, 206-220.
24. Hecker, N., Ahmed, J., von Eichborn, J., Dunkel, M., Macha, K., Eckert, A., Gilson, M.K., Bourne, P.E. and Preissner, R. (2012) SuperTarget goes quantitative: update on drug-target interactions. Nucleic Acids Res., 40, D1113-D1117.
25. Mishra, B.B. and Tiwari, V.K. (2011) Natural products: an evolving role in future drug discovery. Eur. J. Med. Chem., 46, 4769-4807.
26. Siegel, M.G. and Vieth, M. (2007) Drugs in other drugs: a new look at drugs as fragments. Drug Discov. Today, 12, 71-79.
27. Pierson, L.S. and Pierson, E.A. (2010) Metabolism and function of phenazines in bacteria: impacts on the behavior of bacteria in the environment and biotechnological processes. Appl. Microbiol. Biotechnol., 86, 1659-1670.
28. Knox, C., Law, V., Jewison, T., Liu, P., Ly, S., Frolkis, A., Pon, A., Banco, K., Mak, C., Neveu, V. et al. (2011) DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Nucleic Acids Res., 39, D1035-D1041.
29. Ohlendorf, B., Schulz, D., Erhard, A., Nagel, K. and Imhoff, J.F. (2012) Geranylphenazinediol, an acetylcholinesterase inhibitor produced by a Streptomyces species. J. Nat. Prod., 75, 1400-1404.
30. Foulke-Abel, J., Agbo, H., Zhang, H., Mori, S. and Watanabe, C.M. (2011) Mode of action and biosynthesis of the azabicycle-containing natural products azinomycin and ficellomycin. Nat. Prod. Rep., 28, 693-704.
31. Ismail, F.M.D., Levitsky, D.O. and Dembitsky, V.M. (2009) Aziridine alkaloids as potential therapeutic agents. Eur. J. Med. Chem., 44, 3373-3387.
32. Zhao, Q., He, Q., Ding, W., Tang, M., Kang, Q., Yu, Y., Deng, W., Zhang, Q., Fang, J., Tang, G. et al. (2008) Characterization of the azinomycin B biosynthetic gene cluster revealing a different iterative type I polyketide synthase for naphthoate biosynthesis. Chem. Biol., 15, 693-705.
33. Goossens, H., Ferech, M., Stichele, R.V. and Elseviers, M. (2005). ESAC Project Group. (2005) Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet, 365, 579-587.
34. Falagas, M.E., Grammatikos, A.P. and Michalopoulos, A. (2008) Potential of old-generation antibiotics to address current need for new antibiotics. Expert Rev. Anti. Infect. Ther., 6, 593-600.
35. Miro, J.M., Entenza, J.M., Rio, A.D., Velasco, M., Castaneda, X., Garcia de la Maria, C., Giddey, M., Armero, Y., Pericas, J.M., Cervera, C. et al. (2012) High-dose daptomycin plus fosfomycin is safe and effective in treating methicillin-susceptible and methicillin-resistant Staphylococcus aureus endocarditis. Antimicrob. Agents Chemother, 56, 4511-4515.
36. Tran, T.D., Do, T.H., Tran, N.C., Ngo, T.D., Huynh, T.N.P., Tran, C.D. and Thai, K.M. (2012) Synthesis and anti Methicillin resistant Staphylococcus aureus activity of substituted chalcones alone and in combination with non-beta-lactam antibiotics. Bioorg. Med. Chem. Lett., 22, 4555-4560.
37. Ansari, M.Z., Yadav, G., Gokhale, R.S. and Mohanty, D. (2004) NRPS-PKS: a knowledge-based resource for analysis of NRPS/ PKS megasynthases. Nucleic Acids Res., 32, W405-W413.
38. Taboureau, O., Baell, J.B., Fernandez-Recio, J. and Villoutreix, B.O. (2012) Established and emerging trends in computational drug discovery in the structural genomics era. Chem. Biol., 19, 29-41.
39. Cheng, T., Li, Q., Zhou, Z., Wang, Y. and Bryant, S.H. (2012) Structure-based virtual screening for drug discovery: a problem-centric review. AAPS J., 14, 133-141.
40. Jorgensen, W.L. (2009) Efficient drug lead discovery and optimization. Acc. Chem. Res., 42, 724-733.